WO2022229751A1 - Curable fluoroelastomer compositions containing ammonium hydroxybenzoate catalysts - Google Patents
Curable fluoroelastomer compositions containing ammonium hydroxybenzoate catalysts Download PDFInfo
- Publication number
- WO2022229751A1 WO2022229751A1 PCT/IB2022/053212 IB2022053212W WO2022229751A1 WO 2022229751 A1 WO2022229751 A1 WO 2022229751A1 IB 2022053212 W IB2022053212 W IB 2022053212W WO 2022229751 A1 WO2022229751 A1 WO 2022229751A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- group
- composition
- ammonium
- hydroxybenzoate
- cured
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K5/00—Use of organic ingredients
- C08K5/16—Nitrogen-containing compounds
- C08K5/17—Amines; Quaternary ammonium compounds
- C08K5/19—Quaternary ammonium compounds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K5/00—Use of organic ingredients
- C08K5/0008—Organic ingredients according to more than one of the "one dot" groups of C08K5/01 - C08K5/59
- C08K5/0025—Crosslinking or vulcanising agents; including accelerators
Definitions
- the present disclosure relates to curable fluoroelastomer compositions containing compounds having an ammonium cation and an anion comprising a hydroxybenzoate.
- the use of such compounds as catalysts for perfluoroelastomers containing nitrile cure site groups and cured compositions are also described.
- compositions comprising an uncured highly fluorinated elastomer comprising nitrile groups and an ammonium hydroxybenzoate compound according to Formula (I) wherein each R1 group is independently selected from the group consisting of H, OH, R and OR, wherein each R is an alkyl group, provided that at least one R1 group is OH.
- the present disclosure provides cured elastomers prepared from such compositions, including articles comprising cured elastomers.
- Fluoroelastomers can have excellent solvent and temperature resistance. Fluoroelastomers have been cured by a wide variety of mechanisms including the use of cure site monomers and a corresponding catalyst, sometime referred to as a curative. For example, peroxide curing systems have been used with bromine- and iodine-containing cure site monomers.
- nitrile-containing cure site monomers have been used.
- onium catalysts have been used to cure such perfluoroelastomers.
- Commonly used onium catalysts include a low molecular weight fluorinated or perfluorinated anion. It was believed that these fluorinated anions were required to achieve the compatibility with highly fluorinated elastomers needed to allow them to act as effective crosslinking catalysts.
- the present inventors discovered that the non-fluorinated ammonium hydroxybenzoate compounds of the present disclosure are compatible with highly fluorinated elastomers and can provide curing properties comparable to the traditional fluorinated onium catalysts.
- the hydroxybenzoate compounds of the present disclosure can provide improved compression set at high temperatures, improved scorch resistance, or both, as compared to other fluorinated and non-fluorinated onium catalysts.
- the non-fluorinated ammonium compounds of the present disclosure are low molecular weight ammonium hydroxybenzoate compounds.
- a hydroxybenzoate is benzoate derivative substituted by one or more hydroxy groups in any position on the benzene ring, as shown in Formula (I) wherein at least one R1 is OH.
- each R1 is independently H or OH.
- one or more R1 groups may be an alkyl group or an alkoxy group, e.g., a Cl to C4 alkyl or alkoxy group.
- the anion may be a monohydroxybenzoate such as the anion of 2- hydroxybenzoic acid (also referred to as salicylic acid) or 4-hydroxybenzoic acid.
- the benzoate anion may be substituted with two or more hydroxy groups.
- the anion may be a trihydroxybenzoate such as the anion of 3,4,5-trihydroxybenzoic acid (also referred to as gallic acid).
- the anion may include one or more substituents other than hydroxy groups.
- the anion may be a hydroxy-alkyl or hydroxy-alkoxy benzoate such as the anion of 4-hydroxy-3-methoxybenzoic acid (also referred to as vanillic acid).
- a “highly fluorinated” polymer is one in which at least 80 mole%, e.g., at least 90 or even at least 95 mole% of the hydrogen atoms of the polymer backbone have been replaced with fluorine atoms. In some embodiments, 0 to 20 mole%, e.g., 5 to 15 mole% of the hydrogen atoms of the polymer backbone may be replaced with chlorine atoms. In some embodiments, these highly fluorinated polymers may include one or more hydrogen-containing end groups or pendant groups, which are not considered to be part of the polymer backbone.
- the highly fluorinated elastomer is a copolymer of tetrafluoroethylene (TFE) and one or more perfluorinated comonomers.
- at least one perfluorinated comonomer is a perfluoroalkylvinyl ether (PAVE), including perfluoroalkyl alkoxy vinyl ethers.
- PAVEs include perfluoromethyl vinyl ether (PMVE), perfluoroethyl vinyl ether (PEVE), and perfluoropropyl vinyl ether (PPVE-1 and PPVE-2).
- At least one perfluorinated comonomer is a perfluoroalkyl allyl ether (PAAE), including perfluoroalkyl alkoxy allyl ethers.
- PAAEs include perfluoromethyl allyl ether (MA-1), perfluoroethyl allyl ether (MA-2), and perfluoropropyl allyl ether (MA-3).
- At least one perfluorinated comonomer is a perfluorinated alpha-olefin other than TFE, such as hexafluoropropylene (HFP).
- the polymer is a perfluorinated, i.e., at least 99 mole% or even 100 mole% of the hydrogen atoms of the polymer backbone have been replaced with fluorine or chlorine atoms, preferably fluorine atoms. If chlorine atoms are present, they comprise no greater than 20 mole%, e.g., no greater than 10 mole% based on the total moles of fluorine and chlorine atoms on the polymer backbone.
- the perfluorinated polymer comprises no greater than 5 mol%, e.g., no greater than 1 mole%, or even no greater than 0.01 mole% chlorine atoms based on the total moles of fluorine and chlorine atoms on the polymer backbone.
- the highly fluorinated elastomer contains a sufficient number of nitrile groups (CoN) to achieve the desired degree of cure (i.e., crosslinking).
- the elastomer contains at least 0.1 mole % of nitrile groups, e.g., at least 0.5 or even at least 1 mole % of nitrile groups.
- the fluorinated elastomer contains no greater than 5, e.g., no greater than 2 or even no greater than 1.5 mole % of nitrile groups.
- the nitrile groups are introduced by copolymerizing a nitrile-group containing cure site monomer with the other comonomer, e.g., the TFE, PAVE, and PAAE comonomers.
- ammonium hydroxybenzoate compounds of the present disclosure can be used to cure highly fluorinated, nitrile-group containing elastomers. Generally, the ammonium hydroxybenzoate compounds act as catalysts to form triazine crosslinks from the pendant nitrile groups, crosslinking the elastomer to form a cured compound.
- the ammonium hydroxybenzoate compounds can be blended with the highly fluorinated elastomer and formed into articles such as sheets and O-rings using commonly known equipment and methods.
- the compounded elastomer composition can be press cured at temperatures of at least 175 °C, e.g., at least 185 °C.
- the press curing temperature is no greater than 225 °C, or even no greater than 200 °C.
- the extent of cure can be determined according to the Cure Rheology Procedure described in the Examples.
- the press cure time is selected to achieve a desired level of cure, which can be indicated by the Tan d at M j-[ .
- adequate cure is indicated by a Tan d at M j q of no greater than 0.5, e.g., no greater than 0.2, or even no greater than 0.1, as determined according to the Cure Rheology Procedure.
- f 90 (as determined according to the Cure Rheology Procedure ) should be less than 20 minutes, for example no greater than 10 minutes. To minimize the risk of scorching, f 90 should be at least 2 minutes. In some embodiments, longer cure times, e.g., a f 90 value of at least 4 minutes may be beneficial.
- the press cured samples may also be post cured.
- typical post curing temperatures are at least 200 °C, e.g., at least 250 °C and no greater than 325 °C, e.g., no greater than 300 °C.
- Post curing times can depend on a variety of factors including the press curing conditions and the post curing temperature. In some embodiments, post curing times are at least 10 hours, e.g., at least 15 hours. In some embodiments, post curing times of no greater than 30 hours, e.g., no greater than 25 hours are desired.
- the compression set is a critical property.
- the cured compositions of the present disclosure have improved compression set, especially at higher temperatures, e.g., at 250 °C or even 300 °C.
- the cured compositions have a compression set of no greater than 40%, e.g., no greater than 35%, or even no greater than 30%, after 70 hours at 250 °C, as measured in accordance with ASTM D 395-03 Method B and ASTM D 1414-94 with an initial deflection of 25 percent.
- the cured compositions have a compression set of no greater than 40%, e.g., no greater than 35%, or even no greater than 30%, after 70 hours at 300 °C, as measured in accordance with ASTM D 395-03 Method B and ASTM D 1414-94 with an initial deflection of 25 percent.
- ammonium benzoates are commercially available. However, such compounds can also be formed by reacting the corresponding benzoic acid compounds with NH3 e.g., according to the following reaction.
- ammonium benzoate compounds used in the present Examples are summarized in Table 2.
- the compounds were prepared by dissolving the corresponding benzoic acid in a minimum amount of ethanol at room temperature.
- an ammonium hydroxide solution (25-30 wt.% ammonium hydroxide) was gently heated to produce ammonia vapor that was then bubbled through the benzoic acid solutions. Ammonia addition was continued until further heating from the exothermic reaction stopped. During the reaction the ammonium benzoates precipitated from solution.
- the products were vacuum filtered and rinsed with acetone. Remaining solvent was removed in vacuo with a rotary evaporator.
- the ammonium benzoates were obtained as white solids and used without further purification.
- Reference Example REF-1 was prepared using a conventional fluorinated onium catalyst.
- a curable composition was prepared by combining 94 parts by weight of a perfluoroelastomer containing nitrile cure site groups (3MTM DYNEONTM PFE 131 TZ fluoroelastomer from 3M Company) and 7.5 parts by weight of a fluorinated onium catalyst (3MTM DYNEONTM PFE 01CZ catalyst from 3M Company).
- this catalyst product consists of 20% by weight of the fluorinated onium catalyst in 80% by weight of a perfluorinated elastomer
- the result was 100 parts by weight of the perfluorinated resin and 1.5 parts by weight of the catalyst per 100 parts of the perfluorinated resin (i.e., 1.5 phr).
- O-rings (214, AMS AS568) were molded and press-cured at 188 °C for 15 minutes, except for REF-1, which was press-cured for 30 minutes. The press-cured O-rings were then post-cured at 250 °C for 16 hours. The post-cured O-rings were subjected to compression set testing for 70 hours at 250 °C or 300 °C in accordance with ASTM D 395-03 Method B and ASTM D 1414-94 with an initial deflection of 25 percent.
- Example EX-5 was prepared using the same materials as EX-4 including 0.5 phr of ammonium 3,4,5-trihydroxy benzoate as the curative. Samples were prepared and tested according to the methods described above, except that the samples of EX-5 were press-cured at 188 °C for 30 minutes instead of 15 minutes. The compression set measured after 70 hours at 300 °C was 57%.
- the ammonium hydroxybenzoate compounds of the present disclosure can be used in the same curable compositions and cured using the same conditions as the traditional fluorinated onium catalysts. Despite being non-f uorinated, the ammonium hydroxybenzoate compounds can provide the same or similar cure performance without introducing low molecular weight fluorinated compounds. In addition, the use of the ammonium hydroxybenzoate compounds can provide significant improvements in the compression set while maintaining higher t’90 values as compared to the fluorinated onium compound and onium benzoate compounds that have no hydroxy substituents.
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Catalysts (AREA)
Abstract
Compositions comprising an uncured highly fluorinated elastomer comprising nitrile groups and ammonium hydroxybenzoate catalysts that can be used to cure the nitrile-group containing fluoropolymers are described. Cured compositions are also described.
Description
CURABLE FLUOROELASTOMER COMPOSITIONS CONTAINING AMMONIUM HYDROXYBENZOATE CATALYSTS
FIELD
[0001] The present disclosure relates to curable fluoroelastomer compositions containing compounds having an ammonium cation and an anion comprising a hydroxybenzoate. The use of such compounds as catalysts for perfluoroelastomers containing nitrile cure site groups and cured compositions are also described.
SUMMARY
[0002] Briefly, in one aspect, the present disclosure provides compositions comprising an uncured highly fluorinated elastomer comprising nitrile groups and an ammonium hydroxybenzoate compound according to Formula (I)
wherein each R1 group is independently selected from the group consisting of H, OH, R and OR, wherein each R is an alkyl group, provided that at least one R1 group is OH.
[0003] In other aspects, the present disclosure provides cured elastomers prepared from such compositions, including articles comprising cured elastomers.
DETAILED DESCRIPTION
[0004] Fluoroelastomers, particularly perfluorinated elastomers, can have excellent solvent and temperature resistance. Fluoroelastomers have been cured by a wide variety of mechanisms including the use of cure site monomers and a corresponding catalyst, sometime referred to as a curative. For example, peroxide curing systems have been used with bromine- and iodine-containing cure site monomers.
[0005] In high temperature applications, nitrile-containing cure site monomers have been used. In some cases, onium catalysts have been used to cure such perfluoroelastomers. Commonly used onium catalysts include a low molecular weight fluorinated or perfluorinated anion. It was believed that these fluorinated anions were required to achieve the compatibility with highly fluorinated elastomers needed to allow them to act as effective crosslinking catalysts. Surprisingly, the present inventors discovered that the non-fluorinated ammonium hydroxybenzoate compounds of the present disclosure are compatible with highly fluorinated elastomers and can provide curing properties comparable to the traditional fluorinated onium catalysts. Also, in some embodiments, the hydroxybenzoate compounds of the present disclosure can provide improved compression set at high temperatures, improved scorch resistance, or both, as compared to other fluorinated and non-fluorinated onium catalysts.
[0006] Generally, the non-fluorinated ammonium compounds of the present disclosure are low molecular weight ammonium hydroxybenzoate compounds. As used herein, a hydroxybenzoate is benzoate derivative substituted by one or more hydroxy groups in any position on the benzene ring, as shown in Formula (I)
wherein at least one R1 is OH. In some embodiments, each R1 is independently H or OH. In some embodiments, one or more R1 groups may be an alkyl group or an alkoxy group, e.g., a Cl to C4 alkyl or alkoxy group.
[0007] In some embodiments, the anion may be a monohydroxybenzoate such as the anion of 2- hydroxybenzoic acid (also referred to as salicylic acid) or 4-hydroxybenzoic acid. In some embodiments, the benzoate anion may be substituted with two or more hydroxy groups. For example, in some embodiments, the anion may be a trihydroxybenzoate such as the anion of 3,4,5-trihydroxybenzoic acid (also referred to as gallic acid). In some embodiments, the anion may include one or more substituents other than hydroxy groups. For example, in some embodiments, the anion may be a hydroxy-alkyl or hydroxy-alkoxy benzoate such as the anion of 4-hydroxy-3-methoxybenzoic acid (also referred to as vanillic acid).
[0008] The present inventors discovered that, despite using a non-fluorinated anion, these ammonium hydroxybenzoate compounds are compatible with highly fluorinated elastomers.
[0009] As used herein, a “highly fluorinated” polymer is one in which at least 80 mole%, e.g., at least 90 or even at least 95 mole% of the hydrogen atoms of the polymer backbone have been replaced with fluorine atoms. In some embodiments, 0 to 20 mole%, e.g., 5 to 15 mole% of the hydrogen atoms of the polymer backbone may be replaced with chlorine atoms. In some embodiments, these highly fluorinated polymers may include one or more hydrogen-containing end groups or pendant groups, which are not considered to be part of the polymer backbone.
[0010] In some embodiments, the highly fluorinated elastomer is a copolymer of tetrafluoroethylene (TFE) and one or more perfluorinated comonomers. In some embodiments, at least one perfluorinated comonomer is a perfluoroalkylvinyl ether (PAVE), including perfluoroalkyl alkoxy vinyl ethers. Suitable PAVEs include perfluoromethyl vinyl ether (PMVE), perfluoroethyl vinyl ether (PEVE), and perfluoropropyl vinyl ether (PPVE-1 and PPVE-2). In some embodiments, at least one perfluorinated comonomer is a perfluoroalkyl allyl ether (PAAE), including perfluoroalkyl alkoxy allyl ethers. Suitable PAAEs include perfluoromethyl allyl ether (MA-1), perfluoroethyl allyl ether (MA-2), and perfluoropropyl allyl ether (MA-3).
[0011] In some embodiments, at least one perfluorinated comonomer is a perfluorinated alpha-olefin other than TFE, such as hexafluoropropylene (HFP). Additional optional comonomers include partially
fluorinated alpha olefins (e.g., CH2=CF2, VDF), F and Cl containing olefins such as chlorotrifluoroethylene, and non-fluorinated alpha olefins such as ethylene or propylene.
[0012] In some embodiments, the polymer is a perfluorinated, i.e., at least 99 mole% or even 100 mole% of the hydrogen atoms of the polymer backbone have been replaced with fluorine or chlorine atoms, preferably fluorine atoms. If chlorine atoms are present, they comprise no greater than 20 mole%, e.g., no greater than 10 mole% based on the total moles of fluorine and chlorine atoms on the polymer backbone. In some embodiments, the perfluorinated polymer comprises no greater than 5 mol%, e.g., no greater than 1 mole%, or even no greater than 0.01 mole% chlorine atoms based on the total moles of fluorine and chlorine atoms on the polymer backbone.
[0013] Generally, the highly fluorinated elastomer contains a sufficient number of nitrile groups (CºN) to achieve the desired degree of cure (i.e., crosslinking). In some embodiments, the elastomer contains at least 0.1 mole % of nitrile groups, e.g., at least 0.5 or even at least 1 mole % of nitrile groups. In some embodiments, the fluorinated elastomer contains no greater than 5, e.g., no greater than 2 or even no greater than 1.5 mole % of nitrile groups.
[0014] In some embodiments, the nitrile groups are introduced by copolymerizing a nitrile-group containing cure site monomer with the other comonomer, e.g., the TFE, PAVE, and PAAE comonomers. Although not particularly restricted, suitable nitrile-containing cure site monomers include CF2=CF0CF2CF(CF3)0CF2CF2CN, CF2=CFOCF2(CF2)3CF2CN, and CF2=CF0CF2(CF2)3CF(CF3)CN.
[0015] The ammonium hydroxybenzoate compounds of the present disclosure can be used to cure highly fluorinated, nitrile-group containing elastomers. Generally, the ammonium hydroxybenzoate compounds act as catalysts to form triazine crosslinks from the pendant nitrile groups, crosslinking the elastomer to form a cured compound.
[0016] Generally, the ammonium hydroxybenzoate compounds can be blended with the highly fluorinated elastomer and formed into articles such as sheets and O-rings using commonly known equipment and methods. For example, the compounded elastomer composition can be press cured at temperatures of at least 175 °C, e.g., at least 185 °C. In some embodiments, the press curing temperature is no greater than 225 °C, or even no greater than 200 °C. The extent of cure can be determined according to the Cure Rheology Procedure described in the Examples.
[0017] The press cure time is selected to achieve a desired level of cure, which can be indicated by the Tan d at Mj-[. Generally, adequate cure is indicated by a Tan d at Mjq of no greater than 0.5, e.g., no greater than 0.2, or even no greater than 0.1, as determined according to the Cure Rheology Procedure. For most applications, f 90 (as determined according to the Cure Rheology Procedure ) should be less than 20 minutes, for example no greater than 10 minutes. To minimize the risk of scorching, f 90 should be at least 2 minutes. In some embodiments, longer cure times, e.g., a f 90 value of at least 4 minutes may be beneficial.
[0018] In some embodiments, the press cured samples may also be post cured. Although not particularly limited, typical post curing temperatures are at least 200 °C, e.g., at least 250 °C and no
greater than 325 °C, e.g., no greater than 300 °C. Post curing times can depend on a variety of factors including the press curing conditions and the post curing temperature. In some embodiments, post curing times are at least 10 hours, e.g., at least 15 hours. In some embodiments, post curing times of no greater than 30 hours, e.g., no greater than 25 hours are desired.
[0019] In some applications, for examples, O-rings and seals, the compression set is a critical property. In some embodiments, the cured compositions of the present disclosure have improved compression set, especially at higher temperatures, e.g., at 250 °C or even 300 °C. In some embodiments, the cured compositions have a compression set of no greater than 40%, e.g., no greater than 35%, or even no greater than 30%, after 70 hours at 250 °C, as measured in accordance with ASTM D 395-03 Method B and ASTM D 1414-94 with an initial deflection of 25 percent. In some embodiments, the cured compositions have a compression set of no greater than 40%, e.g., no greater than 35%, or even no greater than 30%, after 70 hours at 300 °C, as measured in accordance with ASTM D 395-03 Method B and ASTM D 1414-94 with an initial deflection of 25 percent.
[0020] Examples. Materials used in the preparation of the samples are summarized in Table 1.
[0021] Generally, ammonium benzoates are commercially available. However, such compounds can also be formed by reacting the corresponding benzoic acid compounds with NH3 e.g., according to the following reaction.
[0022] The ammonium benzoate compounds used in the present Examples are summarized in Table 2. The compounds were prepared by dissolving the corresponding benzoic acid in a minimum amount of ethanol at room temperature. In a separate flask, an ammonium hydroxide solution (25-30 wt.% ammonium hydroxide) was gently heated to produce ammonia vapor that was then bubbled through the benzoic acid solutions. Ammonia addition was continued until further heating from the exothermic reaction stopped. During the reaction the ammonium benzoates precipitated from solution. Upon reaction
completion, the products were vacuum filtered and rinsed with acetone. Remaining solvent was removed in vacuo with a rotary evaporator. The ammonium benzoates were obtained as white solids and used without further purification.
[0023] Reference Example REF-1 was prepared using a conventional fluorinated onium catalyst. A curable composition was prepared by combining 94 parts by weight of a perfluoroelastomer containing nitrile cure site groups (3M™ DYNEON™ PFE 131 TZ fluoroelastomer from 3M Company) and 7.5 parts by weight of a fluorinated onium catalyst (3M™ DYNEON™ PFE 01CZ catalyst from 3M Company). As this catalyst product consists of 20% by weight of the fluorinated onium catalyst in 80% by weight of a perfluorinated elastomer, the result was 100 parts by weight of the perfluorinated resin and 1.5 parts by weight of the catalyst per 100 parts of the perfluorinated resin (i.e., 1.5 phr).
[0024] Additional samples were prepared from a curable composition containing 100 parts by weight perfluoroelastomer (3M™ DYNEON™ PFE 131 TZ) and 0.5 phr of various non-fluorinated ammonium benzoate curatives. Comparative Examples CE-1, CE-2 and CE-3 were prepared using 0.5 phr of an ammonium benzoate curative that did not include a hydroxy group. Examples EX-1 to EX-4 were prepared using 0.5 phr of various ammonium hydroxybenzoate curatives. These compounds are summarized in Table 2.
[0025] The samples were press cured and the torque as a function of time was recorded according to the following Cure Rheology Procedure. The results are summarized in Table 3.
[0026] Cure Rheology Procedure. Cure rheology tests were carried out using uncured, compounded samples using a rheometer marketed under the trade designation PPA 2000 by Alpha technologies,
Akron, OH, in accordance with ASTM D 5289-93a at 188 °C, no pre-heat, 60 minutes elapsed time and a 0.5 degree arc. Both the minimum torque (ML) and the maximum torque (Mjq) were measured in units of inch*pounds and converted to dcciNcwtoiTiuctcrs (dNun). If no plateau or maximum torque was obtained, the highest torque attained during the specified period of time was reported as Mjp The time for the torque to reach a value equal to M + 0. l(Mjq - ML), (f 10); the time for the torque to reach a value equal to ML + 0.5(Mjq - ML), (f 50); and the time for the torque to reach ML + 0.9(Mjq - ML), (f 90) were also measured. The ratios of the viscous torque over the elastic torque were determined at the minimum and maximum torque and are reported as the tan d.
[0027] As shown in Table 3, the samples using the non-fluorinated ammonium benzoate and hydroxybenzoate compounds provided similar cure as compared to the conventional fluorinated onium catalyst, as indicated by Tan d at M j values of less than 0.1. However, the t’90 values for each of the benzoate compounds with no hydroxy substituents were less than 2 minutes, which would result in undesired scorching and processing challenges in some applications.
[0028] The samples were also evaluated according to the following Compression Set Procedure. The results are summarized in Table 4, reported as a percentage.
[0029] Compression Set Procedure. O-rings (214, AMS AS568) were molded and press-cured at 188 °C for 15 minutes, except for REF-1, which was press-cured for 30 minutes. The press-cured O-rings were then post-cured at 250 °C for 16 hours. The post-cured O-rings were subjected to compression set testing for 70 hours at 250 °C or 300 °C in accordance with ASTM D 395-03 Method B and ASTM D 1414-94 with an initial deflection of 25 percent.
[0030] As shown by the results in Table 4, the use of the hydroxy-substituted benzoate curatives resulted in substantial improvements in compression set as compared to the fluorinated onium compound, particularly at higher use temperatures.
[0031] Example EX-5 was prepared using the same materials as EX-4 including 0.5 phr of ammonium 3,4,5-trihydroxy benzoate as the curative. Samples were prepared and tested according to the methods described above, except that the samples of EX-5 were press-cured at 188 °C for 30 minutes instead of 15 minutes. The compression set measured after 70 hours at 300 °C was 57%.
[0032] Generally, the ammonium hydroxybenzoate compounds of the present disclosure can be used in the same curable compositions and cured using the same conditions as the traditional fluorinated onium catalysts. Despite being non-f uorinated, the ammonium hydroxybenzoate compounds can provide the same or similar cure performance without introducing low molecular weight fluorinated compounds. In addition, the use of the ammonium hydroxybenzoate compounds can provide significant improvements in the compression set while maintaining higher t’90 values as compared to the fluorinated onium compound and onium benzoate compounds that have no hydroxy substituents.
[0033] The Compression Set Procedure and the Cure Rheology Procedure recited in the attached claims refer to the test methods described in the Example portion of this specification.
Claims
1. A composition comprising
(i) an uncured highly fluorinated elastomer comprising nitrile groups, wherein at least 80 mole% of the hydrogen atoms of the polymer backbone of the highly fluorinated elastomer have been replaced with fluorine atoms; and
2. The composition of claim 1, wherein only one R1 group is OH.
4. The composition of claim 3, wherein each R1 group is H.
6. The composition of claim 5, wherein each R1 group is H.
9. The composition of any one of the preceding claims, wherein at least 95 mole % of the hydrogen atoms of the polymer backbone of the uncured highly fluorinated elastomer have been replaced with fluorine atoms.
10. The composition of any one of the preceding claims, wherein the uncured highly fluorinated elastomer comprises repeating units derived from a perfluorinated monomer comprising a nitrile group, tetrafluoroethylene (TFE), and at least one comonomer selected from the group consisting of a perfluoroalkyl vinyl ether (PAVE) and a perfluoroalkyl allyl ether (PAAE).
11. The composition of any one of the preceding claims, wherein the uncured highly fluorinated elastomer comprises at least 1 mole % and no greater than 5 mole % of nitrile groups.
12. A cured elastomer prepared from the composition according to any one of claims 1 to 11, wherein the uncured highly fluorinated is cured by the ammonium hydroxybenzoate compound to form triazine crosslinks.
13. The cured elastomer of claim 12, having a compression set of no greater than 40% after 70 hours at 300 °C, as measured according to the Compression Set Procedure.
14. The cured elastomer of claim 12 or 13, wherein the cured elastomer has a Tan d at M j of less than 0.1 as measured according to the Cure Rheology Procedure or wherein the composition has t’90 value of at least 2 minutes and no greater than 20 minutes, as measured according to the Cure Rheology Procedure.
15. An article comprising the cured elastomer according to any one of claims 11 to 14.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163182489P | 2021-04-30 | 2021-04-30 | |
| US63/182,489 | 2021-04-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2022229751A1 true WO2022229751A1 (en) | 2022-11-03 |
Family
ID=81327115
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/IB2022/053212 Ceased WO2022229751A1 (en) | 2021-04-30 | 2022-04-06 | Curable fluoroelastomer compositions containing ammonium hydroxybenzoate catalysts |
Country Status (2)
| Country | Link |
|---|---|
| TW (1) | TW202309114A (en) |
| WO (1) | WO2022229751A1 (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5565512A (en) * | 1995-03-31 | 1996-10-15 | Nippon Mektron, Limited | Fluorine-containing elastomer composition |
| WO2020031673A1 (en) * | 2018-08-10 | 2020-02-13 | ダイキン工業株式会社 | Composition, crosslinked rubber molded article and fluorine-containing polymer |
-
2022
- 2022-04-06 WO PCT/IB2022/053212 patent/WO2022229751A1/en not_active Ceased
- 2022-04-25 TW TW111115576A patent/TW202309114A/en unknown
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5565512A (en) * | 1995-03-31 | 1996-10-15 | Nippon Mektron, Limited | Fluorine-containing elastomer composition |
| WO2020031673A1 (en) * | 2018-08-10 | 2020-02-13 | ダイキン工業株式会社 | Composition, crosslinked rubber molded article and fluorine-containing polymer |
| EP3835352A1 (en) * | 2018-08-10 | 2021-06-16 | Daikin Industries, Ltd. | Composition, crosslinked rubber molded article and fluorine-containing polymer |
Non-Patent Citations (1)
| Title |
|---|
| DATABASE WPI Week 202001, Derwent World Patents Index; AN 2020-129822, XP002806952 * |
Also Published As
| Publication number | Publication date |
|---|---|
| TW202309114A (en) | 2023-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5547807B2 (en) | Curing composition for fluoropolymer | |
| JP7706367B2 (en) | Dry powder blends of amorphous perfluorinated polymers, methods for their production, and articles derived from the dry powder blends - Patents.com | |
| JP5873026B2 (en) | Peroxide-cured partially fluorinated elastomer | |
| CN102007150A (en) | Perfluoroelastomers with low carbonyl endgroup ratios | |
| EP3365389A1 (en) | Composition including amorphous fluoropolymer and fluoroplastic particles and methods of making the same | |
| KR20170099947A (en) | Curable partially fluorinated polymer compositions | |
| WO2012135785A1 (en) | Curable fluoroelastomer composition | |
| JP5792916B2 (en) | Curable fluoroelastomer composition | |
| JP6014157B2 (en) | Curing composition for fluoropolymer | |
| WO2022229751A1 (en) | Curable fluoroelastomer compositions containing ammonium hydroxybenzoate catalysts | |
| JP2022165790A (en) | Fluorine-containing copolymer composition, cross-linked rubber article, and manufacturing method of cross-linked rubber article | |
| US12312426B2 (en) | Composition including curable fluoropolymer and curative and methods of making and using them | |
| WO2023233293A1 (en) | Curable fluoropolymer compositions comprising a catalyst and a bis phthalonitrile-containing compound and cured articles therefrom | |
| JP5986311B2 (en) | Curable fluoroelastomer composition | |
| WO2022229752A1 (en) | Curable fluoroelastomer compositions containing quaternary phosphonium hydroxybenzoate catalysts | |
| KR102669338B1 (en) | Curable Fluorinated Polymer Composition | |
| JP7210440B2 (en) | fluoroelastomer composition | |
| WO2025225463A1 (en) | Fluorine-containing copolymer composition, method for producing the same, and fluororubber article | |
| EP4532596A1 (en) | Curable fluoropolymer compositions comprising an ammonium hydroxybenzoate catalyst and a bis phthalonitrile-containing compound and cured articles therefrom |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22715769 Country of ref document: EP Kind code of ref document: A1 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 22715769 Country of ref document: EP Kind code of ref document: A1 |